Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 24.08.2026 1 AJR Am J Roentgenol 1 Br J Radiol 2 Cancer 1 Cancer Imaging 1 Cancer Lett 1 Eur Urol 1 Int J Cancer 2 Int J Urol 1 J Clin Lab Anal 1 J Nucl Med 2 J Urol 1 Proc Natl Acad Sci U S A 1 Radiology 1 Urol Int 1 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DOMONKOS V, Doherty A, Smyth V, Lochocki N, et al
   Prostate MRI in Patients With Incidental Prostate Cancer Diagnosed by Transurethral Resection of the Prostate: Addressing a Guideline Gap.
   AJR Am J Roentgenol. 2026 Aug 19. doi: 10.2214/AJR.26.35470.
   PubMed        
   
   

   
   Br J Radiol

2. SANDOUGHDARAN S, Ezhil V, Mikropoulos C, Conway LJ, et al
   Predictors of relapse in oligometastatic prostate patients receiving stereotactic ablative radiotherapy.
   Br J Radiol. 2026;99:1820-1826.
   PubMed         Abstract available
   
   

   
   Cancer

3. LAWRENCE L
   Estradiol patches noninferior to LHRH agonists in locally advanced prostate cancer.
   Cancer. 2026;132:e70511.
   PubMed        
   
   
4. LAWRENCE L
   PSA monitoring alone proves inadequate for detecting prostate cancer progression.
   Cancer. 2026;132:e70512.
   PubMed        
   
   

   
   Cancer Imaging

5. LI T, Xu N, Yan X, Wang G, et al
   Development and multicohort external validation of a preoperative [18F]PSMA-1007 PET-derived deep learning score and multimodal model for predicting biochemical recurrence-free survival after radical prostatectomy.
   Cancer Imaging. 2026;26:110.
   PubMed         Abstract available
   
   

   
   Cancer Lett

6. LE MAGNEN C, Brennen WN, Aytes A, Bock N, et al
   Patient-Derived Models of Prostate Cancer: Capturing Tumour Complexity from Initiation to Metastasis.
   Cancer Lett. 2026 Aug 19:218791. doi: 10.1016/j.canlet.2026.218791.
   PubMed         Abstract available
   
   

   
   Eur Urol

7. LIGHT A, Peters M, Ahmed HU, Shah TT, et al
   Reply to Marcio C. Moschovas, Ugo Falagario, Francesco Pellegrino, et al's Letter to the Editor re: Alexander Light, Max Peters, Manit Arya, et al's Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer. JAMA Onco
   Eur Urol. 2026 Aug 18:S0302-2838(26)02321-3. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   

   
   Int J Cancer

8. INCORVAIA L, Santini D, Matrana MR, Maruzzo M, et al
   Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations.
   Int J Cancer. 2026 Aug 18. doi: 10.1002/ijc.70679.
   PubMed         Abstract available
   
   

   
   Int J Urol

9. FUJITA K, Makita A, Ishii D, Yamamoto H, et al
   Perioperative Outcomes of Salvage Radical Prostatectomy After Radiation Therapy: A Nationwide Analysis Using the National Clinical Database of Japan.
   Int J Urol. 2026;33:e70602.
   PubMed         Abstract available
   
   
10. IWAMOTO H, Izumi K, Hori T, Inaba T, et al
    Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.
    Int J Urol. 2026;33:e70603.
    PubMed         Abstract available
    
    

    
    J Clin Lab Anal

11. YAGCI E, Ozbayer C, Ozen A, Zengin G, et al
    Analysis of Notch1 and Notch3 Signaling Pathway Components in Benign Prostatic Hyperplasia and Prostate Cancer Patients.
    J Clin Lab Anal. 2026 Aug 18:e70339. doi: 10.1002/jcla.70339.
    PubMed         Abstract available
    
    

    
    J Nucl Med

12. JAFARVAND M, Farolfi A, Mei R, Djaileb L, et al
    PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study.
    J Nucl Med. 2026 Aug 20:jnumed.125.271556. doi: 10.2967/jnumed.125.271556.
    PubMed         Abstract available
    
    

    
    J Urol

13. LEAPMAN MS
    Letter: The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression 2 and Treatment Decisions in Patients with Prostate Cancer on Active Surveillance.
    J Urol. 2026 Aug 21:101097JU0000000000005251. doi: 10.1097/JU.0000000000005251.
    PubMed        
    
    
14. SANDHU S, Teshome H, Van Blarigan EL, Chan JM, et al
    Post-Diagnostic Red Meat, Poultry, and Egg Intake and Risk of Prostate Cancer Progression and Mortality: A Systematic Review.
    J Urol. 2026 Aug 17:101097JU0000000000005263. doi: 10.1097/JU.0000000000005263.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

15. 
    Correction for Wang et al., A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2626818123.
    PubMed        
    
    

    
    Radiology

16. COELHO TF, Bosma JS, Bozgo V, Noordman CR, et al
    Diagnostically Calibrated AI Image Quality Framework Applied to Prostate Cancer Detection at MRI.
    Radiology. 2026;320:e253360.
    PubMed         Abstract available
    
    

    
    Urol Int

17. ALBAYRAK E, Hizarci Bal R, Altan M, Yazici S, et al
    Incidence, Clinicopathological Features, and Survival Impact of Incidental Prostate Cancer in Radical Cystoprostatectomy: A Single-Center Analysis.
    Urol Int. 2026 Aug 20:1-11. doi: 10.1159/000553544.
    PubMed         Abstract available
    
    

    
    Urology

18. TILL C, Tangen CM, Goodman P, Unger JM, et al
    No Evidence of Post-Finasteride Syndrome in 267,983 person-years follow-up in the Prostate Cancer Prevention Trial.
    Urology. 2026 Aug 21:S0090-4295(26)00529-7. doi: 10.1016/j.urology.2026.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum